Researchers at the National Center for Global Health, Italy recently described a novel biotechnological platform for the production of unrestricted cytotoxic T lymphocyte (CTL) vaccines. It relies on in vivo engineering of exosomes, i.e., nanovesicles constitutively released by all cells, ...
Read More »
Exosome RNA Exosome RNA Research & Industry News
